Showing 1 - 5 results of 5 for search 'Viktor P. Volok', query time: 0.03s Refine Results
  1. 1
    Progressive Course of Chronic Tick-Borne Encephalitis Manifesting as Amyotrophic Lateral Sclerosis-like Syndrome 35 Years after the Acute Disease

    Progressive Course of Chronic Tick-Borne Encephalitis Manifesting as Amyotrophic Lateral Sclerosis-like Syndrome 35 Years after the Acute Disease by Viktor P. Volok, Larissa V. Gmyl, Ilmira K. Belyaletdinova, Galina G. Karganova, Evgenii P. Dekonenko

    Published 2022-07-01
    Get full text
    Article
  2. 2
    Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture

    Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture by Mikhail F. Vorovitch, Karina G. Grishina, Viktor P. Volok, Liubov L. Chernokhaeva, Konstantin V. Grishin, Galina G. Karganova, Aidar A. Ishmukhametov

    Published 2020-09-01
    Get full text
    Article
  3. 3
    Development of a Promising Method for Producing Oligomeric Mixture of Branched Alkylene Guanidines to Improve Substance Quality and Evaluate Their Antiviral Activity against SARS-CoV-2

    Development of a Promising Method for Producing Oligomeric Mixture of Branched Alkylene Guanidines to Improve Substance Quality and Evaluate Their Antiviral Activity against SARS-C... by Denis O. Shatalov, Stanislav A. Kedik, Ivan S. Ivanov, Anna V. Aydakova, Diana A. Akhmedova, Dmitrii S. Minenkov, Sergei V. Beliakov, Alexander Herbst, Lasse Greiner, Liubov I. Kozlovskaya, Viktor P. Volok

    Published 2021-06-01
    Get full text
    Article
  4. 4
    Cationic Perylene Antivirals with Aqueous Solubility for Studies In Vivo

    Cationic Perylene Antivirals with Aqueous Solubility for Studies In Vivo by Anna A. Shtro, Anzhelika V. Garshinina, Vera A. Alferova, Polina N. Kamzeeva, Viktor P. Volok, Ekaterina S. Kolpakova, Timofei D. Nikitin, Alexey A. Chistov, Evgeny S. Belyaev, Vladimir A. Korshun, Liubov I. Kozlovskaya, Andrey V. Aralov

    Published 2022-09-01
    Get full text
    Article
  5. 5
    Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts

    Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts by Ilya V. Gordeychuk, Liubov I. Kozlovskaya, Aleksandra A. Siniugina, Nadezhda V. Yagovkina, Vladimir I. Kuzubov, Konstantin A. Zakharov, Viktor P. Volok, Maria S. Dodina, Larissa V. Gmyl, Natalya A. Korotina, Rostislav D. Theodorovich, Yulia I. Ulitina, Dmitry I. Vovk, Marina V. Alikova, Anna A. Kataeva, Anna V. Kalenskaya, Irina V. Solovjeva, Elena V. Tivanova, Larissa Y. Kondrasheva, Antonina A. Ploskireva, Vasiliy G. Akimkin, Ksenia A. Subbotina, Georgy M. Ignatyev, Anastasia K. Korduban, Elena Y. Shustova, Ekaterina O. Bayurova, Alla S. Zhitkevich, Daria V. Avdoshina, Anastasia N. Piniaeva, Anastasia A. Kovpak, Liliya P. Antonova, Yulia V. Rogova, Anna A. Shishova, Yury Y. Ivin, Svetlana E. Sotskova, Konstantin A. Chernov, Elena G. Ipatova, Ekaterina A. Korduban, Aydar A. Ishmukhametov

    Published 2023-08-01
    Get full text
    Article

Search Tools: